Please login to view this media
- Talk
- 18/05/2021
- UK
Outcomes of Debridement, Antibiotics and Implant Retention for Infected Unicompartmental Knee Replacement
Description
This presentation discusses the effectiveness of the DAIR (Debridement, Antibiotics, and Implant Retention) technique for managing early prosthetic joint infections (PJIs) following Unicompartmental Knee Replacement (UKR). The speaker, Abtin Alvand, expresses gratitude to co-authors and outlines the background and necessity for exploring optimal treatment methods for infected knee replacements, noting the increase in patient morbidity and costs associated with various treatment options.
The presentation emphasizes that while the primary goal of DAIR is PJI eradication, a broader assessment framework—encompassing implant survival, mortality rates, and functional outcomes—should be adopted. The study included a total of 19 UKR PJIs treated with DAIR, demonstrating a focus on strict inclusion criteria such as stable components and early infection.
Results indicate a moderate PJI eradication rate of 58%, with a follow-up period averaging 7.5 years. The speaker reveals critical data about common causative organisms, the complications faced, and the overall success of treatment regimens. Emphasizing a multi-disciplinary team (MDT) approach and a robust management protocol, the talk advocates for DAIR as a preferred treatment method in early infections due to its associated benefits, including promising functional outcomes for patients. The study's limitations related to sample size and retrospective design are addressed, reaffirming the necessity for DAIR in appropriate cases.
In conclusion, the speaker advocates for the consideration of DAIR in managing early infections post-UKR, highlighting its effectiveness and appeal for patients.